Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 409

1.

Case-control vaccine effectiveness studies: Preparation, design, and enrollment of cases and controls.

Verani JR, Baqui AH, Broome CV, Cherian T, Cohen C, Farrar JL, Feikin DR, Groome MJ, Hajjeh RA, Johnson HL, Madhi SA, Mulholland K, O'Brien KL, Parashar UD, Patel MM, Rodrigues LC, Santosham M, Scott JA, Smith PG, Sommerfelt H, Tate JE, Victor JC, Whitney CG, Zaidi AK, Zell ER.

Vaccine. 2017 Apr 22. pii: S0264-410X(17)30515-7. doi: 10.1016/j.vaccine.2017.04.037. [Epub ahead of print] Review.

PMID:
28442231
2.

Case-control vaccine effectiveness studies: Data collection, analysis and reporting results.

Verani JR, Baqui AH, Broome CV, Cherian T, Cohen C, Farrar JL, Feikin DR, Groome MJ, Hajjeh RA, Johnson HL, Madhi SA, Mulholland K, O'Brien KL, Parashar UD, Patel MM, Rodrigues LC, Santosham M, Scott JA, Smith PG, Sommerfelt H, Tate JE, Victor JC, Whitney CG, Zaidi AK, Zell ER.

Vaccine. 2017 Apr 22. pii: S0264-410X(17)30513-3. doi: 10.1016/j.vaccine.2017.04.035. [Epub ahead of print] Review.

PMID:
28442230
3.

Avelumab, an Anti-Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study.

Apolo AB, Infante JR, Balmanoukian A, Patel MR, Wang D, Kelly K, Mega AE, Britten CD, Ravaud A, Mita AC, Safran H, Stinchcombe TE, Srdanov M, Gelb AB, Schlichting M, Chin K, Gulley JL.

J Clin Oncol. 2017 Apr 4:JCO2016716795. doi: 10.1200/JCO.2016.71.6795. [Epub ahead of print]

PMID:
28375787
4.

NOMAD spectrometer on the ExoMars trace gas orbiter mission: part 2-design, manufacturing, and testing of the ultraviolet and visible channel.

Patel MR, Antoine P, Mason J, Leese M, Hathi B, Stevens AH, Dawson D, Gow J, Ringrose T, Holmes J, Lewis SR, Beghuin D, van Donink P, Ligot R, Dewandel JL, Hu D, Bates D, Cole R, Drummond R, Thomas IR, Depiesse C, Neefs E, Equeter E, Ristic B, Berkenbosch S, Bolsée D, Willame Y, Vandaele AC, Lesschaeve S, De Vos L, Van Vooren N, Thibert T, Mazy E, Rodriguez-Gomez J, Morales R, Candini GP, Pastor-Morales MC, Sanz R, Aparicio Del Moral B, Jeronimo-Zafra JM, Gómez-López JM, Alonso-Rodrigo G, Pérez-Grande I, Cubas J, Gomez-Sanjuan AM, Navarro-Medina F, BenMoussa A, Giordanengo B, Gissot S, Bellucci G, Lopez-Moreno JJ.

Appl Opt. 2017 Apr 1;56(10):2771-2782. doi: 10.1364/AO.56.002771.

PMID:
28375240
5.

Comparison of cost of care for tethered versus non-tethered ureteric stents in the management of uncomplicated upper urinary tract stones.

Okullo A, Yuminaga Y, Ziaziaris W, Ende D, Lau H, Brooks A, Patel MI, Bariol S.

ANZ J Surg. 2017 Mar 30. doi: 10.1111/ans.13945. [Epub ahead of print]

PMID:
28370915
6.

Comparison of treatment patterns, resource utilization, and cost of care in patients with metastatic pancreatic cancer treated with first-line nab-paclitaxel plus gemcitabine or FOLFIRINOX.

Kim GP, Parisi MF, Patel MB, Pelletier CL, Belk KW.

Expert Rev Clin Pharmacol. 2017 May;10(5):559-565. doi: 10.1080/17512433.2017.1302330. Epub 2017 Apr 19.

PMID:
28286977
7.

A Phase I/Ib Study of Enzalutamide Alone and in Combination with Endocrine Therapies in Women with Advanced Breast Cancer.

Schwartzberg LS, Yardley D, Elias A, Patel M, LoRusso PM, Burris HA, Gucalp A, Peterson A, Blaney M, Steinberg J, Gibbons J, Traina TA.

Clin Cancer Res. 2017 Mar 9. pii: clincanres.2339.2016. doi: 10.1158/1078-0432.CCR-16-2339. [Epub ahead of print]

PMID:
28280092
8.

A Phase I-II Study of the Oral Poly(ADP-ribose) Polymerase Inhibitor Rucaparib in Patients with Germline BRCA1/2-mutated Ovarian Carcinoma or Other Solid Tumors.

Kristeleit R, Shapiro GI, Burris HA, Oza AM, LoRusso PM, Patel M, Domchek SM, Balmaña J, Drew Y, Chen LM, Safra T, Montes A, Giordano H, Maloney L, Goble S, Isaacson J, Xiao J, Borrow J, Rolfe L, Shapira-Frommer R.

Clin Cancer Res. 2017 Mar 6. pii: clincanres.2796.2016. doi: 10.1158/1078-0432.CCR-16-2796. [Epub ahead of print]

PMID:
28264872
9.

Use of m-Health in polio eradication and other immunization activities in developing countries.

Kim SS, Patel M, Hinman A.

Vaccine. 2017 Mar 7;35(10):1373-1379. doi: 10.1016/j.vaccine.2017.01.058. Epub 2017 Feb 9. Review.

PMID:
28190744
10.

Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1).

Drilon A, Siena S, Ou SI, Patel M, Ahn MJ, Lee J, Bauer TM, Farago AF, Wheler JJ, Liu SV, Doebele R, Giannetta L, Cerea G, Marrapese G, Schirru M, Amatu A, Bencardino K, Palmeri L, Sartore-Bianchi A, Vanzulli A, Cresta S, Damian S, Duca M, Ardini E, Li G, Christiansen J, Kowalski K, Johnson AD, Patel R, Luo D, Chow-Maneval E, Hornby Z, Multani PS, Shaw AT, De Braud FG.

Cancer Discov. 2017 Apr;7(4):400-409. doi: 10.1158/2159-8290.CD-16-1237. Epub 2017 Feb 9.

PMID:
28183697
11.
12.

Phase of care prevalence for prostate cancer in New South Wales, Australia: A population-based modelling study.

Yu XQ, Luo Q, Smith DP, Clements MS, Patel MI, O'Connell DL.

PLoS One. 2017 Feb 8;12(2):e0171013. doi: 10.1371/journal.pone.0171013. eCollection 2017.

13.

Osteolipoma of the buccal mucosa: A case report.

Firth NA, Allsobrook OF, Patel M.

Aust Dent J. 2017 Feb 6. doi: 10.1111/adj.12502. [Epub ahead of print]

PMID:
28165623
14.

Teaching urology to medical students: 'is this as good as it gets'?

Patel M, Pleass H.

ANZ J Surg. 2017 Jan;87(1-2):7-8. doi: 10.1111/ans.13812. No abstract available.

PMID:
28156073
15.

Coronary sinus injury resulting from endarterectomy during multivessel bypass surgery.

Akay MH, Patel MK, Gregoric ID.

Interact Cardiovasc Thorac Surg. 2017 Jan 30. pii: ivw393. doi: 10.1093/icvts/ivw393. [Epub ahead of print]

PMID:
28137992
16.

Comparative Effectiveness and Resource Usage in Patients Receiving First-line Taxane-based Chemotherapy for Stage IV Non-Small-cell Lung Cancer in a US Community Oncology Setting.

Weiss J, Force RW, Pugmire BA, Peterson T, Faria C, Margunato-Debay S, Patel MB.

Clin Lung Cancer. 2016 Dec 22. pii: S1525-7304(16)30384-9. doi: 10.1016/j.cllc.2016.12.008. [Epub ahead of print]

PMID:
28117221
17.

The polio endgame: rationale behind the change in immunisation.

Garon J, Patel M.

Arch Dis Child. 2017 Apr;102(4):362-365. doi: 10.1136/archdischild-2016-311171. Epub 2017 Jan 17.

PMID:
28096107
18.

Cancer-related hospitalisations and 'unknown' stage prostate cancer: a population-based record linkage study.

Luo Q, Yu XQ, Smith DP, Goldsbury DE, Cooke-Yarborough C, Patel MI, O'Connell DL.

BMJ Open. 2017 Jan 11;7(1):e014259. doi: 10.1136/bmjopen-2016-014259.

19.
20.

c-Myc-dependent cell competition in human cancer cells.

Patel MS, Shah HS, Shrivastava N.

J Cell Biochem. 2016 Dec 16. doi: 10.1002/jcb.25846. [Epub ahead of print]

PMID:
27982483

Supplemental Content

Loading ...
Support Center